Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short
Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells and deliver targeted radiation.
Search results for "new drug"
The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment
For patients diagnosed with aggressive blood cancers, receiving a proven targeted therapy offers a clear path toward a cure.
GSK Wins Early FDA Approval for Oral Lung Cancer Drug Jideytro Following $10.6 Billion Nuvalent Acquisition
A new oral therapy is now available for patients with ROS1-positive lung cancer whose disease has progressed following...
Daewoong Pharmaceutical Cuts Off Hospital Sales After Domestic Nabota Vials Surface in the U.S.
Daewoong Pharmaceutical announced on July 23 that it has severed supply transactions with a domestic medical...
'2 Million Brain Cells Die Every Minute': Neurologists Call for National Strategy as South Korea Ages
"In a super-aged society, brain diseases represent a core healthcare challenge that the nation must tackle...
Biogen Korea Taps Pharma Veteran Kim Chul-woong as New Country Lead
Biogen Korea has appointed Kim Chul-woong as its new general manager, tapping an executive with extensive expertise in...
Beyond Seoul: How a Secondary Hospital in Busan Mastered 167 Incompatible Kidney Transplants
When a family member steps forward to donate a kidney to a loved one suffering from end-stage renal disease, a blood...
Unlocking the Mystery of Bladder Pain: Researchers Map Cellular Network Driving Interstitial Cystitis
Sharp, stinging pelvic pain and dozens of exhausting trips to the bathroom in a single day—these are the debilitating...
Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production
GC Green Cross has secured priority access to critical manufacturing consumables to stabilize the production of Alyglo,...
Celltrion Secures South Korean Phase 1 Approval for Tremfya Biosimilar CT-P68
Celltrion announced on July 15 that it has received approval from South Korea’s Ministry of Food and Drug Safety for an...